In a bold move, President Trump calls for pharmaceutical companies to justify the success of their Covid drugs amid a leadership crisis at the CDC. As the FDA tightens vaccine eligibility, tensions rise over vaccine efficacy and public health transparency.
CVS has announced major changes to COVID vaccine availability, offering shots in 34 states and requiring prescriptions in 13 others, leaving many Americans confused amid a new variant surge.
AstraZeneca has unveiled an at-home delivery option for its FluMist nasal spray flu vaccine, allowing parents to vaccinate their children without leaving home. This groundbreaking move aims to boost vaccination rates amid declining flu shot coverage.
